Expired
Lead Plaintiff Deadline
Jul 20, 2021
Choose your preferred way to stay informed of new case launches and settlement deadlines
(i) the teplizumab Biologics License Application ("BLA") was deficient in its submitted form and would require additional data to secure U.S. Food and Drug Administration approval; (ii) accordingly, the teplizumab BLA lacked the evidentiary support the Company had led investors to believe it possessed; (iii) the Company had thus overstated the teplizumab BLA’s approval prospects and hence the commercialization timeline for teplizumab; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.
In order to be eligible to join the PRVB class action lawsuit, you must have incurred a loss on shares of Provention Bio purchased during the class period listed above.
If you suffered a loss in Provention Bio during the relevant time frame or pursuant to the relevant offering(s), you have until July 20, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
TOP
